GP anticoagulant 'fear' unwarranted: specialist

ANTICOAGULATION in patients with atrial fibrillation (AF) is just as successful when managed by a GP as it is when managed by a cardiologist, according to data from a global patient registry.

The mortality rate for patients treated with a novel oral anticoagulant (NOAC) under the care of a cardiologist is 1.1%, according to the Global Anticoagulant Registry in the Field (GARFIELD-AF) study, compared with 1.3% in patients managed by GPs.

“There seems to still be fear from some GPs when it comes to